A$127.9 million boost for Australian medical researchers

19 December 2012

Australian Minister for Health Tanya Plibersek this week announced A$127.9 million ($134.8 million) for 151 grants for ground-breaking health and medical research across Australia, noting that, as a result of this investment, medicines were the country’s biggest research-intense goods exports, helping to build a stronger, more competitive and more productive economy.

Ms Plibersek said: “Continued government investment in research enables development of effective new treatments and new policy solutions in our health system. Cures, vaccines and better treatments for HIV are an urgent and global health priority. In Australia, HIV is a serious disease with infections increasing by 8% in 2011,” said Ms Plibersek, adding: “This research will study how HIV can lie dormant in some parts of the body, evading eradication by HIV therapy, as well as how the immune system responds to the virus.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical